A Randomized, Double Blind, Placebo Controlled, Phase III Study of KUC-7483 in Patients With Overactive Bladder
A Randomized, Double Blind, Placebo Controlled, Phase III Study of KUC-7483 in Patients With Overactive Bladder
To evaluate the efficacy and the safety of KUC-7483 in overactive bladder patients.
Inclusion Criteria:
Patients with a symptom of overactive bladder for more than 6 months.
Patients who meet the following condition during the 3-day bladder diary period.
Exclusion Criteria:
Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan